Summary
Using a highly sensitive chemiluminescent enzyme immunoassay, we have evaluated the measurement of serum prostate-specific antigen (PSA) as a potential diagnostic test for differentiation between women with breast cancer and those with benign breast disease. In a controlled study consisting of 284 women with well-documented patient files and matched for age and long-term place of residence, serum samples collected from 90 women with histologically confirmed breast cancer, 94 women with benign breast disease and 100 controls were analysed. Serum total PSA levels in benign breast disease and cancer patients are not statistically different from those of healthy controls. Total PSA levels decrease with age in normal controls and breast cancer patients but not in those with benign breast disease. The total PSA concentration decreases after menopause in healthy women, though not in patients with breast cancer or benign breast disease. Total PSA bore no relation to the histological type or grade of the tumour or the disease stage of the breast cancer patients. In benign breast disease, all mastopathy patients had normal total PSA, whereas elevation of the values was observed in 7% of fibroadenoma patients. Our results show that serum total PSA cannot be used to distinguish between healthy women and/or women with breast cancer or benign breast disease.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Astill, M. E., Rapp, E., Wilson, L. W., Bryson, L. & Wu, J. T. (1996). PSA in breast tumour cytosol: a positive prognostic factor? [Abstract]. Clin Chem 42: S266
Borchert, G. H., Giai, M. & Diamandis, E. P. (1997a). Elevated levels of prostate-specific antigen in serum of women with fibroadenomas and breast cysts. J Natl Cancer Inst 89: 587–588.
Borchert, G. H., Melegos, D. N., Tomlinson, G., Giai, M., Roagna, R., Ponzone, R., Sgro, L. & Diamandis, E. P. (1997b). Molecular forms of prostate-specific antigen in the serum of women with benign and malignant breast diseases. Br J Cancer 76: 1087–1094.
Diamandis, E. P., Yu, H. & Melegos, D. N. (1996). Ultrasensitive prostate-specific antigen assays and their clinical application. Clin Chem 42: 853–857.
Diamandis, E. P., Yu, H. & Sutherland, D. J. A. (1994). Detection of prostate-specific antigen immunoreactivity in breast tumors. Breast Cancer Res Treat 32: 301–310.
Dibbelt, L., Vierke, G. & Wunsche, W. (1996). Prostate-specific antigen immunoreactivity in women with breast cancer [letter]. Clin Chem 42: 1721–1722.
Ferguson, R. A., Yu, H., Kalyvas, M., Zammit, S. & Diamandis, E. P. (1996). Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers. Clin Chem 42: 675–684.
Filella, X., Molina, R., Alcover, J., Carretero, P. & Ballesta, A. M. (1996). Detection of nonprostatic PSA in serum and nonserum samples from women. Int J Cancer 68: 424–427.
Giai, M., Yu, H., Roagna, R., Ponzone, R., Katsaros, D., Levesque, M. A. & Diamandis, E. P. (1995). Prostate-specific antigen in serum of women with breast cancer. Br J Cancer 72: 728–731.
Howarth, D. J. C., Aronson, I. B. & Diamandis, E. P. (1997). Immunohistochemical localization of prostate-specific antigen in benign and malignant breast tissues. Br J Cancer 75: 1646–1651.
Lai, L. C., Erbas, H., Lennard, T. W. & Peaston, R. T. (1996). Prostate-specific antigen in breast cyst fluid: possible role of prostate-specific antigen in hormone-dependent breast cancer. Int J Cancer 66: 743–746.
Mannello, F., Bocchiotti, G., Bianchi, G., Marcheggiani, F. & Gazzanelli, G. (1996). Quantification of prostate-specific antigen immunoreactivity in human breast cyst fluids. Breast Cancer Res Treat 38: 247–252.
Melegos, D. N. & Diamandis, E. P. (1996). Diagnostic value of molecular forms of prostate-specific antigen for female breast cancer. Clin Biochem 29: 193–200.
Witherspoon, L. R. & Lapeyrolerie, T. (1997). Sensitive prostate specific antigen measurements identify men with long disease-free intervals and differentiate aggressive from indolent cancer recurrences within 2 years after radical prostatectomy. J Urol 157: 1322–1328.
Wu, J. T., Zhang, P., Astill, M. E., Wilson, L. W., Lyons, B. W., Wu, L. L. & Stephenson, R. (1995). PSA immunoreactivity detected in LNCaP cell medium, breast tumor cytosol, and female serum. J Clin Lab Anal 9: 243–251.
Yu, H., Giai, M., Diamandis, E. P., Katsaros, D., Sutherland, D. J. A., Levesque, M. A., Roagna, R., Ponzone, R. & Sismondi, P. (1995a). Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res 55: 2104–2110.
Yu, H., Diamandis, E. P., Monne, M. & Croce, C. M. (1995b). Oral contraceptive-induced expression of prostate-specific antigen in the female breast. J Biol Chem 270: 6615–6618.
Yu, H., Diamandis, E. P., Levesque, M., Giai, M., Roagna, R., Ponzone, R., Sismondi, P., Monne, M. & Croce, C. M. (1996). Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue. Breast Cancer Res Treat 40: 171–178.
Yu, H., Levesque, M. A., Clark, G. M. & Diamandis, E. P. (1998). Prognostic value of prostate-specific antigen for women with breast cancer: a large United States cohort study. Clin Cancer Res 4: 1489–1497.
Zarghami, N., Grass, L. & Diamandis, E. P. (1997). Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer. Br J Cancer 75: 579–588.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Romppanen, J., Keskikuru, R., Kataja, V. et al. Measurement of prostate-specific antigen in detection of benign or malignant breast disease in women. Br J Cancer 79, 1583–1587 (1999). https://doi.org/10.1038/sj.bjc.6690252
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690252
Keywords
This article is cited by
-
Reconnoitring the Status of Prostate Specific Antigen and its Role in Women
Indian Journal of Clinical Biochemistry (2015)
-
Serum total PSA and free PSA in breast tumors
Indian Journal of Clinical Biochemistry (2011)
-
Prostate specific antigen in women with menstrual disturbances and fibrocystic mastopathy
Journal of Endocrinological Investigation (2009)
-
Measurement of serum total and free prostate-specific antigen in women with colorectal carcinoma
British Journal of Cancer (2002)